T2 Biosystms Stock Probability of Future Stock Price Finishing Under 1.82
| TTOO Stock | USD 0.49 0.02 3.92% |
TTOO |
T2 Biosystms Target Price Odds to finish below 1.82
The tendency of TTOO Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 1.82 after 90 days |
| 0.49 | 90 days | 1.82 | about 55.98 |
Based on a normal probability distribution, the odds of T2 Biosystms to stay under $ 1.82 after 90 days from now is about 55.98 (This T2 Biosystms probability density function shows the probability of TTOO Stock to fall within a particular range of prices over 90 days) . Probability of T2 Biosystms price to stay between its current price of $ 0.49 and $ 1.82 at the end of the 90-day period is about 46.25 .
Given the investment horizon of 90 days T2 Biosystms has a beta of 0.86. This usually implies T2 Biosystms market returns are highly reactive to returns on the market. As the market goes up or down, T2 Biosystms is expected to follow. Additionally T2 Biosystms has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. T2 Biosystms Price Density |
| Price |
Predictive Modules for T2 Biosystms
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as T2 Biosystms. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.T2 Biosystms Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. T2 Biosystms is not an exception. The market had few large corrections towards the T2 Biosystms' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold T2 Biosystms, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of T2 Biosystms within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -2.87 | |
β | Beta against Dow Jones | 0.86 | |
σ | Overall volatility | 0.92 | |
Ir | Information ratio | -0.48 |
T2 Biosystms Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of T2 Biosystms for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for T2 Biosystms can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| T2 Biosystms generated a negative expected return over the last 90 days | |
| T2 Biosystms has high historical volatility and very poor performance | |
| T2 Biosystms has some characteristics of a very speculative penny stock | |
| T2 Biosystms has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7.19 M. Net Loss for the year was (50.08 M) with loss before overhead, payroll, taxes, and interest of (24.77 M). | |
| T2 Biosystms currently holds about 13.21 M in cash with (48.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| T2 Biosystms has a frail financial position based on the latest SEC disclosures | |
| Roughly 74.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Epicore Biosystems Named to Fast Companys Fourth Annual List of the Next Big Things in Tech |
T2 Biosystms Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of TTOO Stock often depends not only on the future outlook of the current and potential T2 Biosystms' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. T2 Biosystms' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.6 M | |
| Cash And Short Term Investments | 15.7 M |
T2 Biosystms Technical Analysis
T2 Biosystms' future price can be derived by breaking down and analyzing its technical indicators over time. TTOO Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of T2 Biosystms. In general, you should focus on analyzing TTOO Stock price patterns and their correlations with different microeconomic environments and drivers.
T2 Biosystms Predictive Forecast Models
T2 Biosystms' time-series forecasting models is one of many T2 Biosystms' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary T2 Biosystms' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about T2 Biosystms
Checking the ongoing alerts about T2 Biosystms for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for T2 Biosystms help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| T2 Biosystms generated a negative expected return over the last 90 days | |
| T2 Biosystms has high historical volatility and very poor performance | |
| T2 Biosystms has some characteristics of a very speculative penny stock | |
| T2 Biosystms has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7.19 M. Net Loss for the year was (50.08 M) with loss before overhead, payroll, taxes, and interest of (24.77 M). | |
| T2 Biosystms currently holds about 13.21 M in cash with (48.14 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| T2 Biosystms has a frail financial position based on the latest SEC disclosures | |
| Roughly 74.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Epicore Biosystems Named to Fast Companys Fourth Annual List of the Next Big Things in Tech |
Check out T2 Biosystms Backtesting, T2 Biosystms Valuation, T2 Biosystms Correlation, T2 Biosystms Hype Analysis, T2 Biosystms Volatility, T2 Biosystms History as well as T2 Biosystms Performance. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.03) | Revenue Per Share 0.999 | Quarterly Revenue Growth (0.01) | Return On Assets (0.90) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.